How to Buy Alpine Immune Sciences Stock
Alpine Immune Sciences Inc
Alpine Immune Sciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases.
Alpine Immune Sciences stock last closed at $8.59, up 3.12% from the previous day, and has decreased 0.58% in one year. It has overperformed other stocks in the Biotechnology industry by 0.23 percentage points. Alpine Immune Sciences stock is currently +78.22% from its 52-week low of $4.82, and -16.6% from its 52-week high of $10.30.
There are currently 45.91M ALPN shares outstanding. The market value of ALPN is $394.40M. In the past 24 hours, 410,448 ALPN shares were traded.
How to Buy Alpine Immune Sciences Stock
Not sure how to invest in Alpine Immune Sciences stock? Here's how.
- Decide where to buy Alpine Immune Sciences stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Alpine Immune Sciences stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Choose your payment method and add your information.
- Research Alpine Immune Sciences stock: The Alpine Immune Sciences ticker symbol is ALPN. Is Alpine Immune Sciences stock a good investment? Should you buy shares of ALPN? How do ALPN's underlying business fundamentals look? Do top analysts think Alpine Immune Sciences is a good buy? Why has ALPN's stock price moved recently? (Hint: Our stock analysis website can help you decide if ALPN is a good stock to buy).
- Execute your ALPN trade: Decide if you will purchase ALPN shares at the current market price or use a limit order to buy ALPN stock at a particular price.
- Keep tabs on your investment in ALPN: Create a watchlist to watch your position in Alpine Immune Sciences stock.
Step 1: Decide where to buy Alpine Immune Sciences stock
You will need a brokerage account to access the NASDAQ market and buy ALPN stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal information so you can invest in ALPN today.
How to Start a New Brokerage Account on eToro
- Click here to get started.
- Enter your personal info to start your new trading account.
- Submit your application by clicking the "Create Account" button.
Step 3: Deposit money your brokerage account
Now that you have created your account on mobile trading apps, you need to deposit funds:
Check out the video below to see the process of transferring funds into your investment account.
Step 4: Research Alpine Immune Sciences stock
After you have chosen the best place to buy Alpine Immune Sciences stock, it's important to analyze their stock prior to buying, so you can comprehend the risk as well as the opportunity.
Alpine Immune Sciences Metrics
ALPN Overview
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on ALPN's stock page.
Is ALPN stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge ALPN's fair value.
Using relative valuations metrics:
- ALPN may be undervalued based on its P/B ratio of 2.17x, relative to Biotechnology industry P/B ratio of 4.75x
You can do additional valuation analysis on ALPN's stock here.
ALPN Financial Health
Pros:
- ALPN has $248.86M in cash and short term investments. This is enough to cover its annual cash burn of $42.04M.
- There are more short-term assets than long-term liabilities on the ALPN balance sheet.
- ALPN has cash burn of 42042000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the ALPN balance sheet.
Cons:
- Total ALPN debt is higher than 5 years ago, relative to shareholder equity.
- ALPN has a relatively high debt to equity ratio of 0.6.
- ALPN profit margin has gone down from -169% to -169.9% in the past year.
Is Alpine Immune Sciences stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 3 Equities analysts who give recommendations on ALPN, the consensus analyst rating on ALPN is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent ALPN Analyst Recommendations
Michael Ulz, a bottom 12% analyst from Morgan Stanley initiates coverage on ALPN with a strong buy rating and announces their ALPN price target of $17.00, on Jan 19, 2023.
Thomas Smith, a top 14% analyst from SVB Leerink initiates coverage on ALPN with a buy rating and announces their ALPN price target of $16.00, on Nov 21, 2022.
Mark Breidenbach, a bottom 12% analyst from Oppenheimer maintains ALPN with a buy rating and lowers their ALPN price target from $17.00 to $14.00, on Oct 25, 2022.
You can dive deeper into what analysts are saying on the Alpine Immune Sciences stock forecast page.
ALPN Momentum
How is ALPN performing as a company?
Last year, ALPN revenue was $31.82M. During the past 5 year, ALPN's revenue has increased by 68.52% per year. This was faster than the Biotechnology industry average of 51.32%.
You can analyze ALPN's earnings and revenue performance here.
Who is buying/selling ALPN?
In the past year, executives and large shareholders at ALPN have bought more shares than they have sold.
Xiangmin Cui, Director of ALPN, was the latest ALPN insider to buy. They bought $4,700,001.60 worth of ALPN stock on Sep 23, 2022.
Learn more about who owns ALPN stock here.
Can I get consistent income from ALPN stock?
No, Alpine Immune Sciences doesn't provide an income stream by paying out dividends.
ALPN Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your ALPN trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.
Click the Open button and your broker will place the order.
If you want more info about investing in stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your investment in ALPN
Now that you own some shares in ALPN, you'll want to keep up with your stock purchase.
Start a watchlist to track the most important metrics related to your ALPN stock.
ALPN Feed
How to Buy Stock in Alpine Immune Sciences
To summarize, here are the 6 steps to buy Alpine Immune Sciences stock:
- Decide where to buy Alpine Immune Sciences stock
- Create your brokerage account
- Deposit money your brokerage account
- Research Alpine Immune Sciences stock
- Execute your ALPN trade
- Keep tabs on your investment in ALPN
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to watch your investment in Alpine Immune Sciences, click the button below.
Trending Articles
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.